- 全部删除
- 您的购物车当前为空
Fexinidazole (HOE 239) 是具有口服活性的硝基咪唑抗锥虫药物。它显示出对布鲁氏杆菌亚种和菌株的杀锥虫活性,IC50值为 0.7-3.3 μM (0.2-0.9 μg/ml)。它具有用于因感染布鲁氏菌引起的人类昏睡病的潜力。
为众多的药物研发团队赋能,
让新药发现更简单!
Fexinidazole (HOE 239) 是具有口服活性的硝基咪唑抗锥虫药物。它显示出对布鲁氏杆菌亚种和菌株的杀锥虫活性,IC50值为 0.7-3.3 μM (0.2-0.9 μg/ml)。它具有用于因感染布鲁氏菌引起的人类昏睡病的潜力。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥ 133 | 现货 | |
10 mg | ¥ 176 | 现货 | |
25 mg | ¥ 265 | 现货 | |
50 mg | ¥ 372 | 现货 | |
100 mg | ¥ 579 | 现货 | |
200 mg | ¥ 696 | 现货 | |
500 mg | ¥ 1,330 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 235 | 现货 |
产品描述 | Fexinidazole (HOE 239) is an antiparasitic agent. It has activity against Trypanosoma cruzi, Tritrichomonas foetus, Trichomonas vaginalis, Entamoeba histolytica, Trypanosoma brucei, and Leishmania donovani. The biologically relevant active metabolites in vivo are the sulfoxide and sulfone. |
激酶实验 | Promoter-luciferase reporter assay: A 2,767-bp sequence of human survivin gene promoter is isolated from human genomic DNA by PCR using Pyrobest polymerase and the following primers: 5 |
别名 | 非昔硝唑, HOE 239 |
分子量 | 279.31 |
分子式 | C12H13N3O3S |
CAS No. | 59729-37-2 |
Smiles | CSc1ccc(OCc2ncc(n2C)[N+]([O-])=O)cc1 |
密度 | 1.33g/cm3 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 50 mg/mL (179.01 mM), Sonication is recommended. ![]() | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容